Postmenopausal Osteoporosis — Observational Study of Denosumab (Prolia®) in Postmenopausal Women With Osteoporosis
Citation(s)
Prospective Observational Study to Evaluate Medication-taking Behavior With Denosumab (Prolia) and Patient Characteristics in Postmenopausal Women With Osteoporosis in Routine Clinical Practice in Germany, Austria, Greece and Belgium